Corporate Banner
Satellite Banner
Metabolomics & Lipidomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Dundee Team Provides New Insights into Diabetes Treatment

Published: Wednesday, June 06, 2012
Last Updated: Wednesday, June 06, 2012
Bookmark and Share
Scientists to develop more effective ‘second-generation’ medicines in the future.

Researchers from the University of Dundee have made an important discovery about the world’s most commonly prescribed diabetes medicine, which also protects against cancer and cardiovascular disease, opening up the possibility of developing more effective treatments.

The Dundee team, led by Dr Graham Rena of the Department of Cardiovascular and Diabetes Medicine, has furthered understanding of how the type 2 diabetes drug metformin actually works.

They believe this may allow scientists to develop more effective ‘second-generation’ medicines in the future.

Even though the therapeutic action of metformin was first discovered in 1929, the target mediating these effects remained unclear until now.

The Dundee group has discovered that important responses to metformin depend on the drug’s metal-binding properties.

Drugs like metformin have been known to bind to copper since the 19th century, but the role of this in the anti-diabetic effects of the drug was unknown until now.

Dr Rena said, “We have demonstrated that cellular actions of metformin are disrupted by interference with its metal binding properties. This link will illuminate a better understanding of the molecular mechanisms enabling drug action. Further research is now needed to exploit the new tools that we have developed to establish how this unusual property of metformin enables it to be such an effective medicine.”

Metformin is widely used across the globe, and is prioritized over every other treatment option for type 2 diabetes sufferers.

In addition, it is one of only two oral anti-diabetic agents in the World Health Organization’s Model List of Essential Medicines.

Metformin is the best drug for prevention of the cardiovascular complications of diabetes, and has been shown to produce few adverse effects.

This latest study follows work by other investigators in Dundee who were the first to establish that metformin treatment affords type 2 diabetes patients protection against both cancer and cardiovascular disease.

In recent years, it has been shown that metformin displays promise as a treatment for many other conditions and Dr Rena believes this study will further the potential for its use in a number of other situations.

“Metformin is also being investigated for efficacy in a wider range of age-related diseases including cancer, cardiovascular and neurodegenerative disease” he continued.

“Identification of metformin’s target will stimulate the development of second-generation drugs based on metformin, which has been impossible up until now.”

The research, which was funded by Tenovus Scotland, appears in a paper in the current edition of the journal Diabetes.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Launch of DIRECT - An Innovative Medicines Initiative Project for Personalized Medicine in Diabetes
Academia and the pharmaceutical industry working together in the fight against diabetes.
Thursday, February 23, 2012
Dundee Playing Central Role in €12 Million European Union Biomarker Project
The University plays a key role in the research project aiming to find early indicators of cancer types cancer and development of new drugs.
Thursday, May 06, 2010
Scientific News
Accessing Metabolic Information with Mass Spec
Scientists at the Helmholtz Zentrum München have developed a new mass spectrometry imaging method which, for the first time, makes it possible to analyze hundreds of metabolites in fixed tissue samples.
Improving Tumour Therapy with Nanoparticles
UHN nanoparticle called PEARLs is a promising utilisation of photo-thermal therapy for cancer treatment.
Exosome Research and Quality Control Using ZetaView
Particle Matrix's ZetaView particle characterisation system used by Cell Guidance Systems for exosome research.
Natural Metabolite Can Suppress Inflammation
An international group of scientists from US, Canada, Germany and Russia has revealed a substance produced in humans that can suppress the pro-inflammatory activity of macrophages – specific cells of immune system.
Some Women With PCOS May Have Adrenal Disorder
Researchers at NIH have found that a subgroup of women with PCOS, a leading cause of infertility, may produce excess adrenal hormones.
Making Metabolite Identification More Efficient
Metasense combines the industry's most-comprehensive metabolic transformation prediction with efficient analysis of LC/MS analytical measurements to identify, visualize, and report chemical biotransformations.
Mothers Obesity Could be Passed on in mtDNA
Obesity can predispose offspring in multiple generations to metabolic problems.
ASMS 2016: Targeting Mass Spectrometry Tools for the Masses
The expanding application range of MS in life sciences, food, energy, and health sciences research was highlighted at this year's ASMS meeting in San Antonio, Texas.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Copper is Key in Burning Fat
Berkeley Lab scientist says results could provide new target for obesity research.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!